Fil LTD Blueprint Medicines Corp Put Options Transaction History
Fil LTD
- $106 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BPMC
# of Institutions
305Shares Held
54.8MCall Options Held
973KPut Options Held
1.54M-
Black Rock Inc. New York, NY6.65MShares$861 Million0.02% of portfolio
-
Pentwater Capital Management LP Naples, FL3.9MShares$505 Million3.34% of portfolio
-
State Street Corp Boston, MA2.23MShares$289 Million0.01% of portfolio
-
Ubs Group Ag2.17MShares$281 Million0.05% of portfolio
-
Ubs Oconnor LLC Chicago, IL1.71MShares$222 Million9.85% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $7.73B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...